Drug name - Ravicti

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10183005 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs Sep, 2030

(7 years from now)

US10183006 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs Sep, 2030

(7 years from now)

US10045958 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs Sep, 2030

(7 years from now)

US10183003 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs Sep, 2030

(7 years from now)

US10183002 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs Sep, 2030

(7 years from now)

US10183004 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs Sep, 2030

(7 years from now)

US9962359 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs Sep, 2030

(7 years from now)

US8642012 HORIZON THERAP Methods of treatment using ammonia-scavenging drugs Sep, 2030

(7 years from now)

US10045959 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs Sep, 2030

(7 years from now)

US9999608 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs Sep, 2030

(7 years from now)

US9561197 HORIZON THERAP Methods of therapeutic monitoring of phenylacetic acid prodrugs Sep, 2030

(7 years from now)

US10668040 HORIZON THERAP Treatment of urea cycle disorders in neonates and infants Sep, 2030

(7 years from now)

US9254278 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs Mar, 2032

(9 years from now)

US8404215 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging Mar, 2032

(9 years from now)

US9326966 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs Mar, 2032

(9 years from now)

US9095559 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs Mar, 2032

(9 years from now)

Drugs and Companies using GLYCEROL PHENYLBUTYRATE ingredient

Treatment: Treatment of a urea cycle disorder; Dosage adjustment of a nitrogen scavenging drug in the treatment of a urea cycle disorder

Dosage: LIQUID;ORAL

More Information on Dosage
Strength Dosage Availability
1.1GM/ML LIQUID;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.